BETHESDA, MD – October 5, 2018 | ACMG has been awarded a five-year extension of its NICHD contract...
The 2018 NBSTRN Annual Network Meeting: Newborn Screening, Pilots, Genomics and Discoveries is held...
The Mission of the Newborn Screening Translational Research Network (NBSTRN) is to improve the health outcomes of newborns with genetic or congenital disorders by means of an infrastructure that allows investigators access to robust resources for newborn screening research.
This project has been funded in whole or in part with Federal funds from the NICHD, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN275201800005C.
to discover new technology, new treatments, and new diseases in newborn screening